Barclays’s Biomerica BMRA Stock Holding History

Barclays’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11	Buy	+6	New	+$13	﹤0.01%	5298
2021 Q2	–	Sell	-9	Closed	–	–	4871
2021 Q1	$0	Sell	9 -2,991	-100%	-$153K	﹤0.01%	4707
2020 Q4	$120K	Sell	3,000 -1,825	-38%	-$91.4K	﹤0.01%	4051
2020 Q3	$267K	Sell	4,825 -1,438	-23%	-$93K	﹤0.01%	3668
2020 Q2	$363K	Buy	+6,263	New	+$351K	﹤0.01%	3598
2018 Q4	–	Sell	-7	Closed	–	–	6943
2018 Q3	$0	Buy	+7	New	+$210	﹤0.01%	7122

Other funds holding BMRA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Barclays's BMRA Position: Q2 2026 in Review

Barclays opened a new position in Biomerica (BMRA) in Q2 2026: 6 shares worth $11. The stake represents ﹤0.01% of the portfolio and ranks #5298 among its holdings. This is a return to the name: Barclays previously reported a position in BMRA as recently as Q1 2021.

Barclays first reported a position in BMRA in Q3 2018 and has held it in 6 quarters since. The position peaked at $363K in Q2 2020. 20 funds tracked by Wall St. Rank hold BMRA as of Q2 2026.

Barclays held 6 shares of Biomerica worth $11 as of Q2 2026.
Biomerica was a new Barclays position in Q2 2026.
Biomerica made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5298 holding.
Barclays first reported a position in Biomerica in Q3 2018 and has held it in 6 quarters since.
Barclays's Biomerica position peaked at $363K in Q2 2020.
20 funds tracked by Wall St. Rank held Biomerica as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.